HOXB5 promotes retinoblastoma cell migration and invasion via ERK1/2 pathway-mediated MMPs production

被引:2
|
作者
Xu, Haiming [1 ]
Zhao, Hailan [1 ]
Yu, Jie [1 ]
机构
[1] Hangzhou Med Coll, Peoples Hosp, Zhejiang Prov Peoples Hosp, Dept Ophthalmol, 158 Shangtang Rd, Hangzhou 310014, Zhejiang, Peoples R China
来源
关键词
HOXB5; retinoblastoma; invasion; migration; ERK1/2; MMPs; LUNG-CANCER; PROLIFERATION; EXPRESSION; GENES; TRANSITION; CARCINOMA; CATENIN; HOXA1;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Homeobox genes (HOX genes) have been implicated in many tumors. As a member of HOX genes, HOXB5 is overexpressed in bladder cancer and contributes to the proliferation and invasion of breast cancer cells. However, functions of HOXB5 in retinoblastoma remain elusive. In this study, we found that HOXB5 expression is upregulated in retinoblastoma cell lines and tissues. Overexpression of HOXB5 promoted retinoblastoma cell migration and invasion, but knockdown of HOXB5 suppressed the migration and invasion. Moreover, HOXB5 induced the activation of ERK1/2 and upregulated the production of MMP-3 and MMP-13. In addition, ERK1/2 pathway was required for HOXB5-mediated retinoblastoma cell migration and invasion. Taken together, our study suggests that HOXB5 promotes the migration and invasion of retinoblastoma cells by inducing the activation of ERK1/2 and increasing the production of MMP-3 and MMP-13. Therefore, HOXB5 may represent an effective target for treatment of retinoblastoma.
引用
收藏
页码:1703 / 1712
页数:10
相关论文
共 50 条
  • [31] Galectin-3 induces cell migration via a calcium-sensitive MAPK/ERK1/2 pathway
    Gao, Xiaoge
    Balan, Vitaly
    Tai, Guihua
    Raz, Avraham
    ONCOTARGET, 2014, 5 (08) : 2077 - 2084
  • [32] Beta defensin 3 enhances ovarian granulosa cell proliferation and migration via ERK1/2 pathway in vitro
    Liu, Canying
    Pan, Bo
    Yang, Lu
    Wang, Bingyun
    Li, Julang
    BIOLOGY OF REPRODUCTION, 2019, 100 (04) : 1057 - 1065
  • [33] Macrophage migration inhibitory factor (MIF) promotes rat airway muscle cell proliferation and migration mediated by ERK1/2 and FAK signaling
    Lan, Haibing
    Wang, Nan
    Chen, Yu
    Wang, Xiaojing
    Gong, Yuanqi
    Qi, Xiefei
    Luo, Yaling
    Yao, Fang
    CELL BIOLOGY INTERNATIONAL, 2018, 42 (01) : 75 - 83
  • [34] Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal cell carcinoma cells
    Zhao, Yuwan
    Tang, Huancheng
    Zeng, Xin
    Ye, Dongcai
    Liu, Jianjun
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 98 : 36 - 44
  • [35] Methylcobalamin promotes proliferation and migration and inhibits apoptosis of C2C12 cells via the Erk1/2 signaling pathway
    Okamoto, Michio
    Tanaka, Hiroyuki
    Okada, Kiyoshi
    Kuroda, Yusuke
    Nishimoto, Shunsuke
    Murase, Tsuyoshi
    Yoshikawa, Hideki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 443 (03) : 871 - 875
  • [36] p21-activated kinase 4 regulation of endometrial cancer cell migration and invasion involves the ERK1/2 pathway mediated MMP-2 secretion
    Lu, W.
    Xia, Y. H.
    Qu, J. J.
    He, Y. Y.
    Li, B. L.
    Lu, C.
    Luo, X.
    Wan, X. P.
    NEOPLASMA, 2013, 60 (05) : 493 - 503
  • [37] Resistin promotes smooth muscle cell proliferation through activation of the ERK1/2 pathway
    Calabró, P
    Willerson, JT
    Yeh, ET
    EUROPEAN HEART JOURNAL, 2004, 25 : 126 - 127
  • [38] HOXB3 promotes trophoblast cell proliferation, invasion, and migration to alleviate preeclampsia via mediating the Notch/Wnt/β-catenin pathway
    Jia, Xueqin
    Yang, Shiying
    Wang, Xia
    Ruan, Jianbing
    Huang, Wenhua
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 960
  • [39] PTK6 Regulates Migration and Invasion of Pancreatic Cancer Cells With ERK1/2 Dependent Pathway
    Ono, Hiroaki
    Ito, Hiromichi
    Basson, Marc D.
    GASTROENTEROLOGY, 2013, 144 (05) : S1112 - S1112
  • [40] Upregulation of miR-494 promotes cervical cancer cell proliferation, migration and invasion via the MAPK/ERK pathway
    Yu, Nina
    Jin, Jing
    Liu, Jing
    Ma, Ming
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (03): : 3101 - 3108